| Literature DB >> 26958316 |
Kira D Novakofski1, Sarah L Pownder2, Matthew F Koff2, Rebecca M Williams3, Hollis G Potter2, Lisa A Fortier1.
Abstract
Advances in current clinical modalities, including magnetic resonance imaging and computed tomography, allow for earlier diagnoses of cartilage damage that could mitigate progression to osteoarthritis. However, current imaging modalities do not detect submicrometer damage. Developments in in vivo or arthroscopic techniques, including optical coherence tomography, ultrasonography, bioelectricity including streaming potential measurement, noninvasive electroarthrography, and multiphoton microscopy can detect damage at an earlier time point, but they are limited by a lack of penetration and the ability to assess an entire joint. This article reviews current advancements in clinical and developing modalities that can aid in the early diagnosis of cartilage injury and facilitate studies of interventional therapeutics.Entities:
Keywords: CT; MRI; cartilage; imaging; multiphoton microscopy
Year: 2016 PMID: 26958316 PMCID: PMC4749750 DOI: 10.1177/1947603515602307
Source DB: PubMed Journal: Cartilage ISSN: 1947-6035 Impact factor: 4.634
Imaging Techniques.[a]
| Technique | Application | Resolution Range | Clinical Use? | Invasive? |
|---|---|---|---|---|
| Magnetic resonance imaging | 13.7 to 540 μm[ | |||
| T1, T2 | Collagen content from hydration[ | Yes | No | |
| T2* | Collagen from hydration[ | Limited trials | No | |
| T1ρ | Glycosaminoglycan (GAG) concentration from hydration[ | Limited trials | No | |
| dGEMRIC | GAG concentration by dye exlusion[ | Yes | Minimal (injection) | |
| 23Na | GAG concentration[ | Limited trials | No | |
| Computed tomography | ||||
| Contrast (gadopentetate, ioxaglate) | GAG concentration by dye exclusion | Yes | Minimal (injection) | |
| Contrast (anionic) | Measure of GAG concentration | Laboratory | Minimal (injection) | |
| Phase contrast x-ray computed tomography | Matrix inhomogeneity by x-ray scattering[ | 8 µm | Laboratory | No |
| Optical coherence tomography | Matrix inhomogeneity by backscattering of infrared light | 10 µm,[ | Yes | Yes |
| Ultrasonography | Matrix inhomogeneity by sound wave attenuation and refraction | 30 µm,[ | Yes | No, yes (method dependent) |
| Streaming potential measurement | Indirect GAG inhomogeneity with fluctuations in cationic ions[ | Not applicable | Laboratory | No, yes (method dependent) |
| Multiphoton microscopy | Cell death and matrix inhomogeneity with excitation by infrared radiation | <1 µm,[ | Laboratory | Yes |
Magnetic resonance imaging (MRI) and computed tomography (CT), optical coherence tomography (OCT), ultrasonography, electric streaming potential, and multiphoton microscopy (MPM) can be used to acquire data about tissue, which in turn can be used to determine tissue properties. Some of the described methods are currently used clinically, while others are in the process of Food and Drug Administration approval (limited trials), or are still in laboratory development (laboratory). Some methods are noninvasive for the patient, while others require arthroscopy.
Figure 1.Each imaging modality can be used to collect information about the tissue, often in multiple acquisition planes. This information can be combined to provide a comprehensive picture of the tissue. Magnetic resonance imaging (MRI) and computed tomography (CT) provide structural information in sagittal, coronal, and axial (not shown) planes, about full thickness cartilage and subchondral bone. Ultrasonography (US) and optical coherence tomography (OCT) provide information about the structural integrity of cartilage with limited penetration into bone. Multiphoton microscopy (MPM) can be used to acquire axial images with submicron resolution, including the identification of individual cells, but with limited depth penetration from the surface to ~200 µm.